NCT02118753View on ClinicalTrials.gov

The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Ischemia-reperfusion Injury
Interventions
DRUG

Eplerenone

eplerenone administered ex vivo (to the organ bath in which human atrial tissue is exposed)

Trial Locations (1)

6500HB

Radboud University Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02118753 - The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium | Biotech Hunter | Biotech Hunter